1. Home
  2. TWIN vs RZLT Comparison

TWIN vs RZLT Comparison

Compare TWIN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$16.56

Market Cap

276.2M

Sector

Industrials

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.96

Market Cap

326.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
RZLT
Founded
1918
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.2M
326.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TWIN
RZLT
Price
$16.56
$2.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$12.00
$9.14
AVG Volume (30 Days)
38.9K
4.0M
Earning Date
02-04-2026
02-10-2026
Dividend Yield
0.99%
N/A
EPS Growth
128.02
N/A
EPS
1.54
N/A
Revenue
$348,096,000.00
N/A
Revenue This Year
$10.79
N/A
Revenue Next Year
$8.43
N/A
P/E Ratio
$10.50
N/A
Revenue Growth
8.31
N/A
52 Week Low
$6.16
$1.07
52 Week High
$19.63
$11.46

Technical Indicators

Market Signals
Indicator
TWIN
RZLT
Relative Strength Index (RSI) 45.73 42.82
Support Level $15.03 $3.15
Resistance Level $19.63 $3.38
Average True Range (ATR) 1.09 0.26
MACD -0.17 0.11
Stochastic Oscillator 32.83 26.56

Price Performance

Historical Comparison
TWIN
RZLT

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: